CN Stock MarketDetailed Quotes

002437 Harbin Gloria Pharmaceuticals

Watchlist
  • 1.82
  • +0.01+0.55%
Market Closed Jul 26 15:00 CST
4.13BMarket Cap27.16P/E (TTM)

Harbin Gloria Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2023/FY
Stock NameRevenueRatio
Nutritional drugs1.08B41.29%
Cardio-cerebrovascular drugs679.83M25.89%
Orthopedic drugs270.4M10.30%
Electrolyte drugs235.66M8.97%
Antitumor drugs177.04M6.74%
Antiinfective drugs63.41M2.41%
Other34.7M1.32%
Digestive system drugs34.03M1.30%
抗肝炎药物25.24M0.96%
其他用药领域21.33M0.81%
View all
Industry Currency:CNY
2023/FY
Stock NameRevenueRatio
化药行业2.52B95.86%
Traditional Chinese medicine industry100.96M3.84%
Other7.8M0.30%
Region Currency:CNY
2023/FY
Stock NameRevenueRatio
Domestic2.62B99.91%
Abroad2.36M0.09%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg